International Hospital Development in Sichuan Province and Beyond
In 2019, UPMC and China-based multinational conglomerate Wanda Group signed a far-reaching strategic cooperation agreement to jointly build and operate multiple world-class hospitals in China.
UPMC will provide expertise in hospital design, operations, and management best practices that will meet the highest international quality standards. Wanda UPMC Chengdu Hospital, under development, will be the first location to open. By collaborating in the development and management of these hospitals, both UPMC and Wanda Group are engaging in a valuable exchange of knowledge and expertise, while bringing patients the highest quality medical care as close to home as possible.
Wanda Group is one of the world's largest real estate, film, children’s entertainment, sports, and tourism companies. Its expansion into health care is guided by China’s national “Healthy China 2030” policy, which encourages private investments to supplement the public hospital system.
Continued Collaboration with Xiangya Hospital
In 2014, UPMC and Xiangya Hospital of Central South University elevated their decade-long research and clinical collaboration by partnering to develop the Xiangya International Medical Center located in Changsha.
Under the agreement, UPMC provides Xiangya Hospital with technical, clinical, administrative, and management services, including:
- Medical and administrative training based in Pittsburgh and China
- Quality assurance and safety practices
- Technology recommendations
- Equipment and staffing plans
- Telemedicine links to UPMC’s clinical programs in Pittsburgh and Italy
In 2011, UPMC entered into an agreement with KingMed Diagnostics, the largest independent medical diagnostic laboratory in China.
Through this partnership, UPMC’s Department of Pathology provides second opinions for high-acuity anatomical pathology cases. Using equipment that scans glass pathology slides and stores and transmits the images electronically, KingMed receives second opinions on patient diagnoses from our UPMC pathologists through a secure, web-based telepathology portal.
The agreement provides KingMed's patients with rapid access to UPMC’s expert pathologists, thereby helping to ensure accurate diagnoses of complex diseases. KingMed pathologists based in China also have the opportunity to train at UPMC facilities in Pittsburgh as part of their ongoing medical education.
U.S.-China Healthcare Cooperation Program (HCP)
UPMC is a founding member of the U.S.-China Healthcare Cooperation Program (HCP), a public-private partnership of 18 companies and 10 nonprofit organizations.
Supported by United States governmental agencies and the Chinese Ministries of Health and Commerce, HCP is a vehicle for the two countries to work together in:
- Technical collaboration
- Capacity building
- Market development
HCP not only supports health care projects in information technology, but also rural health initiatives, quality and safety, and hospital management.